[January 26, 2016]

Great Basin's Sandra Nielsen Recognized with Utah Business Annual Sales & Marketer of the Year (SAMY) Award

Great Basin Scientific, Inc. (NASDAQ:GBSN), a molecular diagnostics company, today announced that Utah Business magazine has honored Sandra Nielsen, Vice President, Sales, Marketing & HR with a 2016 SAMY award. The Utah Business SAMY awards aim to recognize Utah's top sales and marketing professionals who have had a measurable impact on their company's bottom line. Ms. Nielsen will accept her award later today during the SAMY Honoree Award Luncheon held at the Grand America Hotel in Salt Lake City.

Ms. Nielsen spearheads Great Basin's global sales and marketing efforts, leads the customer/technical support operations, and oversees product management and user experience, as well as corporate communications and public relations efforts. In her role, she supports Great Basin's continuing efforts to empower health providers to accurately diagnose infectious disease and define a clear treatment path sooner for improved patient outcomes, shorter hospital stays and dollars saved in hospitalization costs per patient.

"Sandra's passion and drive are not only admirable, but they are clearly genuine, and contagious throughout the entire organization," said Ryan Ashton, co-founder and Chief Executive Officer of Great Basin. "Her work ethic and dedication inspire her team of talented sales and marketing professionals to go the extra mile for our customers and the organization. We are grateful for Sandra's unwavering commitment and we commend her on this well-deserved recognition."

Ms. Nielsen has worked at Utah-based high-tech start-ups since the mid 1990's serving in a variety of marketing, public relations and communications roles. Since she assumed leadership of the Great Basin Sales organization in August 2014, Great Basin has decreased its sales cycle from 61 days to 30 days, grown the customer win rate from 76 to 86 percent, and has grown the customer base from 84 to 186 sites as of the end of 2015.

"It's an honor to be acknowledged among such an accomplished group of sales and marketing leaders throughout the state of Utah," said Ms. Nielsen. "I'm passionate about the work we do at Great Basin and am fortunate to work with a team as committed as I to improving patient outcomes in hospitals every day."

The SAMY honorees will be featured in the January 2016 edition of Utah Business magazine. For more information, visit http://www.utahbusiness.com/events/samy-awards/.

About Great Basin Scientific

Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company's vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. More information can be found on the company's website at www.gbscience.com.

Forward-Looking Statements

This press release includes forward-looking statements regarding the Company's continuing business efforts related to its products, including but not limited to, assistance of health providers to define a clear treatment path sooner for improved patient outcomes, shorter hospital stays and dollars saved in hospitalization costs per patient, the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases and related statements. Forward-looking statements involve risk and uncertainties, which could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risk and uncertainties include, but are not limited to: (i) our limited operating history and history of losses; (ii) our ability to develop and commercialize new products and the timing of commercialization; (iii) our ability to obtain capital when needed; and (iv) other risks set forth in the Company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2015. These forward-looking statements speak only as of the date hereof and Great Basin Scientific specifically disclaims any obligation to update these forward-looking statements, except as required by law.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160126005330/en/

[ Back To TMCnet.com's Homepage ]